NCT03396367Completed
Prevention and Risk: Treatment With a New Emphasis on Relationships
Intervention to Reduce Drug Use and HIV Incidence Among High PrEP Priority Partnered YMSM
Source: ClinicalTrials.gov · Last updated 29 Oct 2025
Brief summary (registry, in English)
This research examines the efficacy of an individually-delivered intervention tailored for YMSM in relationships. The intervention - termed PARTNER - utilizes a brief (4 session) motivational interviewing format to target Pre-Exposure Prophylaxis (PrEP) uptake/adherence, HIV transmission risk behavior, and associated drug use.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 196 (actual)
- First submitted
- 4 Jan 2018
- Start date
- 14 Feb 2018
- Primary completion date
- 21 Feb 2024
- Lead sponsor
- Hunter College of City University of New York
- Diseases
- HIV
- NCT number
- NCT03396367
What you commit to
- Study type: Interventional
- Participants enrolled: 196
- From 14 Feb 2018 to the primary completion date, 21 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection of the Structured Clinical Interview for DSM-IV);
- Evidence of gross cognitive impairment (a score of \<24 on the mini-mental state examination)
- A history of severe physical or sexual Intimate Partner Violence (IPV) victimization in the current relationship in which participants report not currently feeling "safe" in their relationship and/or coerced to participate in the study.
Other
- Current suicidal/homicidal ideation;
Who the study is looking for
- 18 to 29 years of age (inclusive);
- Main partner must be aged 18 or older.
- Must be in a main partner relationship with another male (duration ≥ 1 months);
- HIV-negative serostatus (confirmed by rapid test);
- Recent (past 30 day) use of at least one of the substances identified as most commonly used by YMSM (marijuana, cocaine, methamphetamine, heroin or other opiates, MDMA, psychedelics, GHB, and/or ketamine);
- Sexual behavior meeting CDC criteria for PrEP candidacy (TRB with a casual partner in the past 30 days or TRB with a non-monogamous or serodiscordant main partner).
- Participants must reside in the NYC metro area
- Ability to communicate in English
Age in the registry: 18 years to 29 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hunter College- City University of New York Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.